EUVIMEDEUVIMED entdecken
Fallbericht

Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report

Kazuhiko Hashimoto iD, Tomohiko Ito, Yuto Yamagishi, Koji Goto

Modern Rheumatology Case Reports · 2025

DOI: 10.1093/mrcr/rxae059 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Kazuhiko Hashimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Kindai University Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Denosumab, Breast Neoplasms, Femoral Fractures, Bone Density Conservation Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 54-year-old woman developed stage IV breast cancer 8 years prior. Chemotherapy was administered, and she was started on zoledronic acid treatment for her bone metastases. Her chemotherapy regimen was then switched, owing to disease progression. Fifty-seven months after starting treatment with zoledronic acid, the patient suffered an atypical femoral fracture of her right femur, for which she underwent surgery. Twenty months later, she developed another atypical femoral fracture in her left femur and underwent intramedullary nail fixation. Zoledronic acid and denosumab use in patients with metastatic bone tumours caused by breast cancer should be done cautiously, considering atypical femoral fracture risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabBreast NeoplasmsFemoral FracturesBone Density Conservation AgentsImidazolesDiphosphonatesBone NeoplasmsHumansFemaleZoledronic AcidMiddle AgedFracture Fixation, Intramedullary

Stichwörter der Autor:innen

Atypical femoral fracturebonebreast cancerdenosumabzoledronic acid

Substanzen

Zoledronic AcidDenosumabBone Density Conservation AgentsImidazolesDiphosphonates

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Kindai University Hospital, Osaka, Japan.

ORCID-Profile: Kazuhiko Hashimoto

Zitieren

APA

Hashimoto, K., Ito, T., Yamagishi, Y., & Goto, K. (2025). Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxae059

Vancouver

Hashimoto K, Ito T, Yamagishi Y, Goto K. Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxae059

BibTeX
@article{Hashimoto2025,
  author = {Hashimoto, Kazuhiko and Ito, Tomohiko and Yamagishi, Yuto and Goto, Koji},
  title = {Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report},
  journal = {Modern Rheumatology Case Reports},
  year = {2025},
  doi = {10.1093/mrcr/rxae059}
}
Kostenlos starten →